期刊文献+

乳腺癌患者肿瘤组织中髓源抑制性细胞的临床意义 被引量:5

Clinical significance of myeloid-derived suppressor cells in breast cancer tissues
原文传递
导出
摘要 目的:研究乳腺癌患者肿瘤组织中髓源抑制性细胞(myeloid-derived suppressor cells,MDSCs)与乳腺癌临床病理特征的关系。方法:收集天津肿瘤医院2009年2月至2009年12月间35例乳腺癌根治术的手术切除组织标本,制成单细胞悬液;流式细胞术检测其中MDSCs(Lin-CD33+CD13+CD14-CD15-)比例,免疫组化法检测同一肿瘤组织中ER、PR、Her-2表达;分析MDSCs比例与患者临床病理特征的关系。结果:乳腺癌患者肿瘤组织中MDSCs比例与临床分期、淋巴结转移有关,Ⅲ期患者MDSCs比例[(11.70±7.85)%]高于Ⅰ/Ⅱ期患者[(5.32±4.59)%],发生3个以上淋巴结转移患者的MDSCs比例[(10.97±7.87)%]高于3个以下(含3个)淋巴结转移的患者[(5.86±5.26)%](P<0.05)。未观察到MDSCs比例高低与患者年龄、病理类型、肿瘤直径、组织学分级,以及ER、PR、Her-2表达有关(P>0.05)。结论:乳腺癌患者肿瘤组织中MDSCs比例与患者临床分期、淋巴结转移有关,MDSCs增多可能是乳腺癌患者发生免疫抑制的重要原因之一。 Objective:To examine the myeloid-derived suppressor cells(MDSCs) in breast cancer tissues and their relationship with clinicopathological characteristics of breast cancer.Methods: Thirty-five breast cancer samples were obtained from Tianjin Cancer Hospital(from Feb.2009 to Dec.2009),and single cell suspensions were prepared.The proportions of MDSCs(Lin-CD33+CD13+CD14-CD15-)in breast cancer tissues were determined by flow cytometry.Immunohistochemistry was used to detect the expressions of ER,PR,Her-2 proteins in the same tumor tissues.Then we analyzed the correlation of MDSCs ratio with clinical characteristics of breast cancer.Results: The MDSCs ratio in breast cancer tissues was correlated with the clinical stage and metastasis lymph node numbers in breast cancer patients,with the ratio in stage Ⅲ breast cancer patients([11.70±7.85]%) being significantly higher than that in stage Ⅰ/Ⅱ patients([5.32±4.59]%).Patients with more than 3 metastasis lymph nodes had a higher MDSCs ratio([10.97±7.87]%) than patients with less than 3 metastasis lymph nodes([5.86±5.26]%,P〈0.05).MDSCs ratio was not correlated with ages,pathologic types,tumor diameters,histological grades,or expressions of ER,PR and Her-2 of breast cancer patients(P〉0.05).Conclusion: The MDSCs ratio in breast cancer tissues is correlated with the clinical stage and lymph node metastasis of breast cancer,and the increased MDSCs numbers may be an important reason of immune suppression in breast cancer patients
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2010年第5期545-548,共4页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金资助项目(No.30972694) 天津市高等学校科技发展基金(No.20090133)~~
关键词 乳腺癌 髓源抑制性细胞 流式细胞术 breast cancer myeloid-derived suppressor cell flow cytometry
  • 相关文献

参考文献13

  • 1Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, Montero AJ. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorabicin-eyclophosphamide chemotherapy [ J ].Cancer Immunol Immunother, 2009, 58( 1 ) : 49-59.
  • 2沈春,于津浦,李慧,曹水,刘俊田,孙敬岩,辛宁,安秀梅,于文文,任秀宝.乳腺癌患者髓系来源抑制性细胞的鉴定与免疫作用研究[J].中国肿瘤临床,2009,36(17):1010-1015. 被引量:7
  • 3Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: Linking inflammation and cancer [J]. J Immunol, 2009, 182 (8) : 4499-4506.
  • 4hiu CY, Wang YM, Wang CL, Feng PH, Ko HW, Liu YH, et al. Population alterations of L: -arginase- and inducible nitric oxide synthase-expressed CDllb ( + )/CD14 (-)/CD15 ( + )/ CD33 ( + ) myeloid-derived suppressor cells and CD8 ( + ) T lymphocytes in patients with advanced-stage non-small cell lung cancer [ J ]. J Cancer Res Clin Oncol, [ 2010-03-09 ]. http :// www. ncbi. nlm. nih. gov/pubmed.
  • 5Kusmartsev S, Su Z, Heiser A, Dannull J, Eruslanov E, Ktibler H, et al. Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma [ J ]. Clin Cancer Res, 2008, 14(24) : 8270-8278.
  • 6Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor ceils as regulators of the immune system [ J]. Nat Rev Immunol, 2009, 9 (3) : 162-174.
  • 7刘秋燕,曹雪涛.MDSCs与肿瘤免疫逃逸[J].中国肿瘤生物治疗杂志,2009,16(4):319-324. 被引量:24
  • 8Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity [ J ]. Blood, 2008, 111 ( 8 ) : 4233-4244.
  • 9Youn JI, Nagaraj S, Collazo M, Gabrilovich DI, et al. Subsets of myeloid-derived suppressor cells in tumor-bearing mice [ J ]. J Immunol, 2008, 181(8): 5791-5802.
  • 10Ko JS, Zea All, Rini BI, Ireland JL, Elson P, Cohen P, et al. Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients [ J]. Clin Cancer Res, 2009, 15(6) : 2148-2157.

二级参考文献49

  • 1Liu Q, Zhang C, Sun A, et al. Tumor-educated CD11b^high Ia^low regulatory dendritic cells suppress T cell response through arginase Ⅰ [J]. J Immunol, 2009, 182(10) :6207-6216.
  • 2Chung DJ, Rossi M, Romano E, et al. Indoleamine 2,3-dioxygenase- expressing mature human monocyte-derived dendritic ceils expand potent autologous regulatory T cells [ J]. Blood, 2009,114 (3) : 555 -563.
  • 3Nardin A, Abastado JP. Macrophages and cancer [ J ]. Front Biosci, 2008,13 (3) : 494-505.
  • 4Ko JS, Bukowski RM, Fincke JH. Myeloid-derived suppressor cells: a novel therapeutic target [J]. Curr Oncol Rep, 2009, 11 (2) : 87-93.
  • 5Youn JI, Nagaraj S, Collazo M, et al. Subsets of myeloid-derived suppressor cells in tumor-bearing mice [ J]. J Immunol, 2008, 181 ( 8 ) :5791-5802.
  • 6Hestdal K, Ruscetti FW, Ihle JN, et al. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells [J]. J Immunol, 1991, 147(1) : 22-28.
  • 7Dietlin TA, Hofman FM, Lund BT, et al. Mycobacteria-induced Gr-1^+ subsets from distinct myeloid lineages have opposite effects on T cell expansion [J]. J Leukoc Biol, 2007, 81 (5) : 1205- 1212.
  • 8Almand B, Clark JI, Nikitina E, et al. Gabrilovich. Increased production of immature myeloid cells in cancer patients : a mechanism of immunosuppression in cancer [ J]. J Immunol, 2001, 166( 1 ) : 678-689.
  • 9Schmielau J, Finn OJ. Activated granulocytes and granulocytederived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients [ J ].Cancer Res, 2001,61 (12) : 4756-4760.
  • 10Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow [J] ? Lancet, 2001, 357(9255): 539-545.

共引文献29

同被引文献43

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部